Sign in
Stories
Diagnostics Distribution Deals Analysis 2024
Share
89bio to Present pegozafermin for NASH a...
ANJESO Drug Insight and Market Forecast
Acquisition Progress Amid Safety Concern
Advancing OSE-279: Promising Cancer Trea...
Aligos Therapeutics Financial Disclosure
Biosimilar HLX14 Succeeds in Trials
Overview
API
ResearchAndMarkets.com's report 'Distribution Deals in Diagnostics 2016 to 2024' delves into the trends and analysis of distribution deals in the diagnostics sector over the past eight years. It offers detailed information on payment terms, deal structures, and key distribution deals, while showcasing the top 25 most active dealmakers. The report encompasses a thorough directory of distribution deals categorized by companies, therapy areas, and technology types.
Ask a question
How have payment terms in distribution deals within the diagnostics sector evolved over the analyzed period?
How might the trends identified in this report influence future strategies for companies involved in diagnostics distribution deals?
What impact do leading distribution deals have on the competitive landscape of the diagnostics industry?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage